CellTrend GmbH 代理
简要描述：CellTrend 代理，CellTrend 上海代理，CellTrend 北京代理， CellTrend 代理, CellTrend 一级代理， CellTrend 代理上海金畔生物科技有限公司 CellTrend 专业代理，具体产品信息欢迎电询：021-50837765
详细介绍
产品咨询
世界*实验材料供应商 CellTrend上海金畔生物为其中国代理， CellTrend在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔生物一直秉承为中国科研客户带来的产品，的服务， CellTrend就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获
CellTrend中国代理, CellTrend上海代理， CellTrend北京代理，CellTrend广东代理， CellTrend江苏代理CellTrend湖北代理,CellTrend天津,CellTrend黑龙江代理,CellTrend内蒙古代理,CellTrend吉林代理,CellTrend福建代理, CellTrend江苏代理, CellTrend浙江代理, CellTrend四川代理,
公司：http://www.celltrend.de
CellTrend GmbH was founded in 1998 and has ten employees. CellTrend is a biotechnology company and is working as a contract research organisation for the pharmaceutical industry. CellTrend is performing cell based Bioassayswith the focus oncology and immunology.
Furthermore, CellTrend develops, produces, and distributes Immuno-Assayse.g. ELISAs (enzyme linked immuno sorbend assay), a quick and sensitive analytical method that is characterized by specific binding of antibodies to analytes. Various validated diagnostic and research test kits are available. If required, samples are analysed in CellTrend laboratories. We also offer to develop new ELISAs for your analytes.
CellTrend is certified according to ISO 9001:2008, ISO 13485:2003 (medical devices), and ISO 13485:2003 CMDR (Canada Medical Devices Regulation). Our Total Quality Management affects all processes and has been developed to fulfill our customers' needs. Our personnel are extensively knowledged and practically trained. We strictly adhere to the rules of GMP (Good Manufacturing Practice, FDA).
In 2006 CellTrend developed the ELISA for the determination of Auto-Antibodies against the Angiotensin-II-Receptor-I. The assay is worldwide patent (European patent number 1393076). The assay is validated according the Guidance for Industry: Bioanalytical Method Validation, US FDA May 2001.
上海金畔生物科技有限公司